文献速递物质与行为成瘾

美国成人甲基苯丙胺使用、甲基苯丙胺使用障碍及相关过量死亡

Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该横断面研究分析2015至2019年美国全国药物使用与健康调查(NSDUH)中18至64岁人群数据,并结合全国生命统计系统多死因档案。结果发现涉及非可卡因类精神兴奋剂的过量死亡增加180%,甲基苯丙胺使用、频繁使用、合并可卡因使用及未注射的甲基苯丙胺使用障碍(MUD)均呈上升趋势,MUD或注射使用在2017至2019年比例超过无MUD且非注射使用。

要点

  • 2015至2019年涉及非可卡因类精神兴奋剂的过量死亡增加180%。
  • MUD或注射使用者在2017至2019年占比60%至67%,高于无MUD且非注射使用者的37%至40%。
  • 低教育、低收入、无保险、住房不稳定、涉司法、共病及自杀意念等为风险因素。

核心结论

  • 2015至2019年美国甲基苯丙胺使用、MUD、注射及频繁使用和相关过量死亡均呈上升趋势,高危人群日趋多样化。

关键数值与推荐

  • MUD或注射使用者在2017至2019年占比60%至67%,无MUD且非注射使用者占比37%至40%(P for trend ≤.001)。
  • MUD或注射使用者更易频繁使用甲基苯丙胺(52.68%-53.84% vs 32.59%;调整风险比1.62-1.65;95%CI 1.35-1.94)。
  • 未注射MUD调整患病率在异性恋女性中从0.24%升至0.74%,在女同性恋或双性恋女性中从0.21%升至0.71%(均P < .001)。
  • 未注射MUD调整患病率在异性恋男性中从0.29%升至0.79%,在男同性恋或双性恋男性中从0.29%升至0.80%(P < .001与P = .007)。
  • 未注射MUD调整患病率在黑人中从0.06%升至0.64%,在白人从0.28%升至0.78%,在西班牙裔从0.39%升至0.82%(均P < .001)。

临床怎么用

  • 提示临床应关注甲基苯丙胺使用及MUD的上升趋势,尤其对低教育、低收入、无保险、住房不稳定、涉司法、共病及自杀意念人群加强筛查与干预。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mortality associated with methamphetamine use has increased markedly in the US. Understanding patterns of methamphetamine use may help inform related prevention and treatment. OBJECTIVE: To assess the national trends in and correlates of past-year methamphetamine use, methamphetamine use disorder (MUD), injection, frequent use, and associated overdose mortality from 2015 to 2019. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed methamphetamine use, MUD, injection, and frequent use data from participants in the 2015 to 2019 National Surveys on Drug Use and Health (NSDUH). Mortality data were obtained from the 2015 to 2019 National Vital Statistics System Multiple Cause of Death files. EXPOSURES: Methamphetamine use. MAIN OUTCOMES AND MEASURES: Methamphetamine use, MUD, injection, frequent use, and overdose deaths. RESULTS: Of 195 711 NSDUH respondents aged 18 to 64 years, 104 408 were women (weighted percentage, 50.9%), 35 686 were Hispanic individuals (weighted percentage, 18.0%), 25 389 were non-Hispanic Black (hereafter, Black) individuals (weighted percentage, 12.6%), and 114 248 were non-Hispanic White (hereafter, White) individuals (weighted percentage, 60.6%). From 2015 to 2019, overdose deaths involving psychostimulants other than cocaine (largely methamphetamine) increased 180% (from 5526 to 15 489; P for trend <.001); methamphetamine use increased 43% (from 1.4 million [95% CI, 1.2-1.6 million] to 2.0 million [95% CI, 1.7-2.3 million]; P for trend = .002); frequent methamphetamine use increased 66% (from 615 000 [95% CI, 512 000-717 000] to 1 021 000 [95% CI, 860 000-1 183 000]; P for trend = .002); methamphetamine and cocaine use increased 60% (from 402 000 [95% CI, 306 000-499 000] to 645 000 [95% CI, 477 000-813 000]; P for trend = .001); and MUD without injection increased 105% (from 397 000 [95% CI, 299 000-496 000] to 815 000 [95% CI, 598 000-1 033 000]; P for trend = .006). The prevalence of MUD or injection surpassed the prevalence of methamphetamine use without MUD or injection in each year from 2017 to 2019 (60% to 67% vs 37% to 40%; P for trend ≤.001). Adults with MUD or using injection were more likely to use methamphetamine frequently (52.68%-53.84% vs 32.59%; adjusted risk ratio, 1.62-1.65; 95% CI, 1.35-1.94). From 2015 to 2019, the adjusted prevalence of MUD without injection more than tripled among heterosexual women (from 0.24% to 0.74%; P < .001) and lesbian or bisexual women (from 0.21% to 0.71%; P < .001) and more than doubled among heterosexual men (from 0.29% to 0.79%; P < .001) and homosexual or bisexual men (from 0.29% to 0.80%; P = .007). It increased over 10-fold among Black individuals (from 0.06% to 0.64%; P < .001), nearly tripled among White individuals (from 0.28% to 0.78%; P < .001), and more than doubled among Hispanic individuals (from 0.39% to 0.82%; P < .001). Risk factors for methamphetamine use, MUD, injection, and frequent use included lower educational attainment, lower annual household income, lack of insurance, housing instability, criminal justice involvement, comorbidities (eg, HIV/AIDS, hepatitis B or C virus, depression), suicidal ideation, and polysubstance use. CONCLUSIONS AND RELEVANCE: This cross-sectional study found consistent upward trends in overdose mortality, greater risk patterns of methamphetamine use, and populations at higher risk for MUD diversifying rapidly, particularly those with socioeconomic risk factors and comorbidities. Evidence-based prevention and treatment interventions are needed to address surges in methamphetamine use and MUD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Han B, Compton WM, Jones CM, et al. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021. PMID: 34550301. doi:10.1001/jamapsychiatry.2021.2588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。